These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 365193)
1. [Treatment with antilymphocyte globulin (ALG) and evolution of renal transplant: observations of 42 cases]. Civati G; Grillo C; Di Belgioioso GB; Rovati C; Surian M; Busnach G; Broggi L; Ferrari L Boll Ist Sieroter Milan; 1978 May; 57(2):165-72. PubMed ID: 365193 [TBL] [Abstract][Full Text] [Related]
2. A randomized prospective clinical trial of antilymphocyte globulin in 100 cadaveric renal transplants. Sansom JR; Barnes AD; Hall CL Postgrad Med J; 1976; 52(5 Suppl):75-8. PubMed ID: 792851 [TBL] [Abstract][Full Text] [Related]
3. Canadian clinical trial of antilymphocyte globulin in human cadaver renal transplantation. Taylor HE; Ackman CF; Horowitz I Can Med Assoc J; 1976 Dec; 115(12):1205-8. PubMed ID: 793705 [TBL] [Abstract][Full Text] [Related]
4. Antilymphocyte globulin for the treatment of steroid non-responsive acute renal allograft rejection. Griffin PJ; Williams GT; Salaman JR Clin Nephrol; 1984 Feb; 21(2):115-7. PubMed ID: 6373078 [TBL] [Abstract][Full Text] [Related]
5. Early function as the principal correlate of graft survival. A multivariate analysis of 200 cadaveric renal transplants treated with a protocol incorporating antilymphocyte globulin and cyclosporine. Halloran PF; Aprile MA; Farewell V; Ludwin D; Smith EK; Tsai SY; Bear RA; Cole EH; Fenton SS; Cattran DC Transplantation; 1988 Aug; 46(2):223-8. PubMed ID: 3043779 [TBL] [Abstract][Full Text] [Related]
6. Antilymphocyte globulin and renal transplantation. Tagnon A Postgrad Med J; 1976; 52(5 Suppl):64-6. PubMed ID: 792848 [TBL] [Abstract][Full Text] [Related]
7. The use of antilymphocyte globulin in renal allograft rejection. A controlled study. Birkeland SA Postgrad Med J; 1976; 52(5 Suppl):82-8. PubMed ID: 792853 [TBL] [Abstract][Full Text] [Related]
8. Individualization of immediate posttransplant immunosuppression. The value of antilymphocyte globulin in patients with delayed graft function. Matas AJ; Tellis VA; Quinn TA; Glicklich D; Soberman R; Veith FJ Transplantation; 1988 Feb; 45(2):406-9. PubMed ID: 3278434 [TBL] [Abstract][Full Text] [Related]
9. [Evaluation of the effectiveness of ALG in clinical kidney transplantation in alternating studies]. Tidow G; Bunzendahl H; Wonigeit K; Pichlmayr R Chir Forum Exp Klin Forsch; 1979; ():325-8. PubMed ID: 378593 [TBL] [Abstract][Full Text] [Related]
11. Antilymphocyte globulin with a small dose of cyclosporine A and prednisone as the induction of immunosuppression in renal allograft recipients. Boratyńska M; Szepietowski T; Szewczyk Z; Szydłowski Z Arch Immunol Ther Exp (Warsz); 1992; 40(2):163-8. PubMed ID: 1299176 [TBL] [Abstract][Full Text] [Related]
12. Alternative antirejection treatment with steroids or antilymphoblast globulin in renal transplant patients receiving cyclosporine. Veremis SA; Maddux MS; Pollak R; Kline SS; Mozes MF Transplant Proc; 1987 Feb; 19(1 Pt 3):1893-5. PubMed ID: 3079056 [TBL] [Abstract][Full Text] [Related]
13. 20-year follow-up results of a randomized controlled trial comparing antilymphocyte globulin induction to no induction in renal transplant patients. Cantarovich M; Durrbach A; Hiesse C; Ladouceur M; Benoit G; Charpentier B Transplantation; 2008 Dec; 86(12):1732-7. PubMed ID: 19104413 [TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of immunological findings for the survival time of kidney transplants with antilymphocyte globulin therapy]. Bullinger W; Hammer C; Land W; Welter H Chir Forum Exp Klin Forsch; 1979; ():319-24. PubMed ID: 378592 [TBL] [Abstract][Full Text] [Related]
16. Beneficial effect of concomitant induction with antilymphoblast globulin, cyclosporine, and steroids on long-term renal allograft outcome. Koga A; Moreso FJ; Seron D; Gil-Vernet S; Cruzado JM; Castelao AM; Grinyó JM Transplant Proc; 2004 Jun; 36(5):1305-7. PubMed ID: 15251318 [TBL] [Abstract][Full Text] [Related]
17. Experience with antilymphocyte globulin in 144 renal transplant recipients. Lundgren G; Collste L; Groth CG; Krzymansky M; Magnusson G; Quadracci L; Ringdén O; Svehag SE Postgrad Med J; 1976; 52(5 Suppl):67-71. PubMed ID: 792849 [TBL] [Abstract][Full Text] [Related]
18. Cadaveric kidney transplantation under prophylactic polyclonal antibody immunosuppression with anti-lymphoblast globulin versus anti-thymocyte globulin. Indudhara R; Novick AC; Hodge E; Goormastic M; Papajcik D; Mastroianni B; Cook D Urology; 1996 Jun; 47(6):807-12. PubMed ID: 8677568 [TBL] [Abstract][Full Text] [Related]
19. Controlled trial of antilymphocyte globulin in cadaveric transplantation. Jakobsen J; Flatmark A; Sodal G; Thorsby E Postgrad Med J; 1976; 52(5 Suppl):72-4. PubMed ID: 792850 [TBL] [Abstract][Full Text] [Related]
20. [Kidney retransplantation: prognostic factors in a series of 84 cases]. Gutierrez R; Romero JA; Ricart JM; Barranco M; Oppenheimer P; Alvarez R; Talbot R; Carretero P J Urol (Paris); 1992; 98(2):84-8. PubMed ID: 1431189 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]